LL-37 5mg
$74.99
Availability: 20 in stock
LL-37 is a synthetic antimicrobial peptide derived from the cathelicidin family, which is known for its role in the innate immune system. It is the only member of the cathelicidin family found in humans and plays a critical role in the bodys defense against pathogens, including bacteria, viruses, and fungi. LL-37 exhibits broad-spectrum antimicrobial activity, wound healing properties, and immunomodulatory effects. Due to its ability to modulate immune responses and promote tissue repair, LL-37 has become a subject of extensive research in various fields, including infectious disease, wound healing, and inflammatory responses.
LL-37: A Comprehensive Overview for Biology and Medical
Researchers
What is LL-37?
LL-37 is a synthetic antimicrobial peptide derived from the cathelicidin family, which is known for its role in the innate immune system. It is the only member of the cathelicidin family found in humans and plays a critical role in the bodys defense against pathogens, including bacteria, viruses, and fungi. LL-37 exhibits broad-spectrum antimicrobial activity, wound healing properties, and immunomodulatory effects. Due to its ability to modulate immune responses and promote tissue repair, LL-37 has become a subject of extensive research in various fields, including infectious disease, wound healing, and inflammatory responses.
Chemical Structure and Properties
LL-37 is a 37-amino acid peptide characterized by its amphipathic structure, which allows it to interact with lipid membranes effectively.
- Amino Acid Sequence: LLGDFFRKSKEKIGKEFKRIVQRI
- Molecular Formula: C₁₈H₃₁N₆O₅S
- Molecular Weight: Approximately 4505.0 g/mol
- CAS Number: 133128-17-0
- PubChem CID: [To be added if available]
The structure of LL-37 enables it to disrupt bacterial membranes, facilitating its antimicrobial effects while also promoting wound healing and modulating immune functions.
LL-37 Research
Research on LL-37 has revealed its multifaceted role in the immune system and its potential therapeutic applications:
1. Antimicrobial Activity:
a. LL-37 has shown potent antimicrobial properties against a wide range of pathogens, including multidrug-resistant strains. Studies indicate that LL- 37 can kill bacteria by disrupting their cell membranes and inhibiting their growth (Mackintosh et al., 2009).
2. Wound Healing:
a. Research suggests that LL-37 promotes wound healing by enhancing keratinocyte migration and proliferation while modulating inflammatory responses. LL-37 has been shown to facilitate repair processes in various tissue types, making it a candidate for treatments in chronic or acute wounds (Frohm et al., 2004).3. Immunomodulatory Functions:
a. LL-37 plays a significant role in modulating the immune response. It is known to influence the activity of various immune cells, including macrophages and mast cells, and can promote pro-inflammatory or anti- inflammatory responses depending on the context (Liu et al., 2017).
4. Role in Inflammatory Diseases:
a. Elevated levels of LL-37 have been associated with inflammatory conditions, such as psoriasis and rheumatoid arthritis. Thus, research suggests its potential as a biomarker for disease activity and severity (Özdemir et al., 2014).
Future Research Directions
Future research on LL-37 holds promise and may focus on the following key areas:
1. Clinical Applications:
a. More clinical studies are needed to evaluate the therapeutic potential of LL-37 in treating infections, particularly with antibiotic-resistant bacteria, and its application in wound healing protocols for various settings.
2. Mechanistic Studies:
a. Further investigations into the precise mechanisms by which LL-37 exerts its antimicrobial and immunomodulatory effects will be essential for understanding its multifaceted role in health and disease.
3. Combination Therapies:
a. Exploring the synergistic effects of LL-37 in combination with other antimicrobial agents or wound-healing compounds could enhance therapeutic efficacy and offer new strategies against infections.
4. Long-Term Effects and Safety:
a. Research needs to assess the long-term safety and efficacy of LL-37 applications, especially in clinical and acute care settings, to ensure safe usage in human populations.
Scientific References and Further Reading
1. Mackintosh, C. A., et al. (2009). The role of LL-37 in the regulation of
antimicrobial function and tissue repair. Clinical Science.
https://doi.org/10.1042/CS20090186
2. Frohm, M., et al. (2004). The wound healing properties of LL-37. International
Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.14.4.657
3. Liu, Y., et al. (2017). LL-37: A promising candidate for wound healing and
regeneration. Wound Repair and Regeneration.
https://doi.org/10.1111/wrr.12566
Disclaimer
This information is for research and educational purposes only. LL-37 is not
approved for human use and is intended solely for in vitro studies and
experimental applications.
